![Ulrich Kalinke](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ulrich Kalinke
Vorstandsvorsitzender bei Twincore, Zentrum für Experimentelle und Klinische
Aktive Positionen von Ulrich Kalinke
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Twincore, Zentrum für Experimentelle und Klinische
![]() Twincore, Zentrum für Experimentelle und Klinische Miscellaneous Commercial ServicesCommercial Services Twincore, Zentrum für Experimentelle und Klinische, is a research institute based in Hannover, Germany. Twincore specializes in translational infection research, with a focus on viral infections, respiratory infections, and organ-specific immunity and metabolism research. The German company also conducts pre-clinical and clinical studies on vaccines and antiviral antibodies. Twincore has an international team of over 40 scientists from more than 20 nations, and the private company places a strong emphasis on international collaboration and exchange programs. The company has organized several symposiums and publishes research papers on various topics related to infection research. The company was founded in 2008, and the CEO is Ulrich Kalinke. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Ulrich Kalinke
Statistik
International
Deutschland | 2 |
Operativ
Chief Executive Officer | 1 |
Sektoral
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Twincore, Zentrum für Experimentelle und Klinische
![]() Twincore, Zentrum für Experimentelle und Klinische Miscellaneous Commercial ServicesCommercial Services Twincore, Zentrum für Experimentelle und Klinische, is a research institute based in Hannover, Germany. Twincore specializes in translational infection research, with a focus on viral infections, respiratory infections, and organ-specific immunity and metabolism research. The German company also conducts pre-clinical and clinical studies on vaccines and antiviral antibodies. Twincore has an international team of over 40 scientists from more than 20 nations, and the private company places a strong emphasis on international collaboration and exchange programs. The company has organized several symposiums and publishes research papers on various topics related to infection research. The company was founded in 2008, and the CEO is Ulrich Kalinke. | Commercial Services |
- Börse
- Insiders
- Ulrich Kalinke
- Erfahrung